QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Adaptive Biotechnologies (ADPT) Insider Trading & Ownership

$4.16
+0.12 (+2.97%)
(As of 02/26/2024 ET)

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$2.36 M
Get ADPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adaptive Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ADPT Insider Buying and Selling by Quarter


Adaptive Biotechnologies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2023Kyle PiskelInsiderSell259$4.13$1,069.67  
8/7/2023Nitin SoodInsiderSell5,652$6.78$38,320.56  
6/20/2023Tycho PetersonCFOSell134,961$8.14$1,098,582.54  
6/15/2023Tycho PetersonCFOSell70,000$8.53$597,100.00  
6/2/2023Tycho PetersonCFOSell38,000$7.16$272,080.00  
4/10/2023R Mark AdamsCOOSell817$8.50$6,944.50  
3/27/2023Michelle Renee GriffinDirectorSell2,341$8.49$19,875.09  
3/6/2023Julie RubinsteinPresidentSell22,668$8.57$194,264.76  
3/6/2023Kyle PiskelInsiderSell3,529$8.57$30,243.53  
3/6/2023R Mark AdamsCOOSell6,529$8.57$55,953.53  
3/6/2023Stacy L TaylorSVPSell5,491$8.57$47,057.87  
(Data available from 1/1/2013 forward)












ADPT Insider Trading Activity - Frequently Asked Questions

Who is on Adaptive Biotechnologies's Insider Roster?
What percentage of Adaptive Biotechnologies stock is owned by insiders?

5.20% of Adaptive Biotechnologies stock is owned by insiders. Learn more on ADPT's insider holdings.

Which Adaptive Biotechnologies insiders have been selling company stock?

The following insiders have sold ADPT shares in the last 24 months: Chad M Robins ($237,727.14), Julie Rubinstein ($249,666.89), Kyle Piskel ($39,819.53), Lance Baldo ($28,499.73), Michelle Renee Griffin ($19,875.09), Nitin Sood ($479,437.76), R Mark Adams ($127,787.42), Stacy L Taylor ($65,901.56), and Tycho Peterson ($1,967,762.54).

How much insider selling is happening at Adaptive Biotechnologies?

Insiders have sold a total of 374,626 Adaptive Biotechnologies shares in the last 24 months for a total of $3,216,477.66 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ADPT) was last updated on 2/26/2024 by MarketBeat.com Staff